Myoglobin ELISA
2Pages

Juronen, E.L., Viikmaa, M.H., and Mikelsarr, A.V.N.: Rapid, simple and sensitive antigen capture ELISA for the quantitation of myoglobin using monoclonal antibodies, J. Imm. Meth.: 111, 109; (1988). Chapelle JP. et al.: Serum myoglobin determinations in the assessment of acute myocardial infarction. Eur. Heart Journal, 3:122, (1982). Cairns, J.P., et.al.: Usefulness of serial determinations of myoglobin and creatine kinase in serum compared for assessment of acute myocardial infarction, Clin. Chem. News, 29: 469, (1983). Silva, D.P., et.al.: Development and application of antibodies to human cardiac myoglobin in rapid fluolrescence immunoassay, Clin. Chem., 37: 1356, (1991). Ellis AK.: Patters of myoglobin release after reperfusion of injured myocardium. Clin. Chem., 72:639, (1985). Mair J. et al.: Rapid diagnosis of myocardial infarction by immunoturbidimetric myoglobin measurement (letter). Lancet, ;337:1343, (1991). Chapelle, J.P.: Myoglobin. Clin. Chem. News, 17:22, (1991). Hamfelt, A., et. al.: Use of biochemical tests for myocardial infarction in the county of Vasternorrland, a clinical chemistry routine for the diagnosis of myocardial infarction. Scand. J. Clin. Lab. Invest. Suppl., 200:20, (1990). Tucker, J.F., et.al.: Early diagnostic efficiency of cardiac troponin I and Troponin T for acute myocardial infarction, Academic Emergency Medicine: 4(1): 13-21; (1997). de Winter, R.J., et.al.: Value of myoglobin, troponin T and CK-Mbmass in ruling out an acute myocardial infarction in the emergency room, Circulation: 92(12): 3401-7; (1995). Montague, C., Kircher, T.: Myoglobin in early evaluation of acute chest pain, Amer. J. Clin. Path.: 104(4): 472-6; (1995). Tucker, J.F., et.al., Value of serial myoglobin levels in the early diagnosis of patients admitted for acute myocardial infarction, Annals of Emergency Medicine: 24(4): 704-8; (1994). Roxin, L.E., et.al.: The value of serum myoglobin determinations in the early diagnosis of acute myocardial infarction, Acta Medica Scand.: 215(5): 417-25; (1984). Sylven, C., Bendz, R.: Myoglobin, creatine kinase and its isoenzyme MB in serum after acute myocardial infarction, Eur. J. Cardiol.: 8(4-5): 515-21; (1978). Norregaard-Hansen, K., et. al.: Early observations of S-myoglobin in the diagnosis of acute myocardial infarction. The influence of discrimination limit, analytical quality, patient’s sex, and prevalence of disease. Scand. J. Clin. Lab. Invest., 46:561-569, (1986). Engvall, E., “Methods in Enzymology”, Volume 70, VanVunakis H. and Langone, J.J. (eds.), Academic Press, New York, NY, 419-492, (1980). Uotila, M., Ruouslahti, E. And Engvall, E., J. Immunol. Methods, 42, 11-15, (1981). U.S. Department of Labor, Occupational Safety and Health Administration, 29 CFR Part 1910.1030. Occupational Exposure ot Bloodborne Pathogens; Final Rule. Federal Register; 56(235):64175, (1991). USA Center for Disease Control/National Institute of Health Manual, “Biosafety in Microbiological and Biomedical Laboratories”, (1984). National Committee for Clinical Laboratory Standards. Protection of Laboratory Workers from Instrument Biohazards and Infectious Disease Transmitted by Blood, Body Fluids, and Tissue: Approved Guideline. NCCLS Document M29-A, (1997). Clinical Guide to Laboratory Tests. N.W. Tietz, Ed., 3rd Edition, W.B. Saunders, Co., p. 482, (1995). 2017-04-17 Cat#: MG017C (96 Tests) For Order and Inquiries, please contact Calbiotech Inc., 1935 Cordell Ct., El Cajon, CA 92020 Tel (619) 660-6162, Fax (619) 660-6970, www.calbiotech.com Myoglobin ELISA Catalog No.: MG017C (96 Tests) INTENDED USE The Calbiotech Inc. (CBI) Myoglobin ELISA Kit is intended for the quantitative determination of Myoglobin in human serum or plasma. SUMMARY AND EXPLANATION Myoglobin, a heme protein with a molecular weight of approximately 17,500 Daltons is found in both cardiac and skeletal muscle. Damage to either type of muscle following conditions such as trauma, ischemia, and diseases that cause myopathy, is associated with the release of myoglobin into serum. Specifically, following cardiac necrosis associated with myocardial infarction (MI), myoglobin is one of the first markers to rise above normal levels. Myoglobin levels increase measurably above baseline within 2-4 hours post-infarct, peaking at 9-12 hours, and returning to baseline within 24-36 hours. In the absence of skeletal muscle trauma or other factors associated with a non-cardiac related increase in circulating myoglobin, its levels have been used as an early marker for myocardial infarct. A number of reports suggest using the measurement of myoglobin as a diagnostic aid in ruling out myocardial infarction with negative predictive values of up to 100% reported at certain time periods after the onset of symptoms.915 Unlike the other cardiac enzymes such as creeatine kinase and the MB isoform (i.e., CK and CK/MB) which do not reach serum levels until several hours post-infarction (approx. 19 hours), myoglobin levels can be expected to peak within 6 to 9 hours. The Myoglobin Enzyme Immunoassay provides a rapid, sensitive, and reliable assay for the quantitative measurement of myoglobin in serum. The antibodies developed for the test will determine a minimal concentration of 5.0 ng/ml, and there is no cross-reactivity with related cardiac or skeletal enzymes. PRINCIPLE OF THE TEST The Myoglobin ELISA test is based on the principle of a solid phase enzyme-linked immunosorbent assay. The assay system utilizes a unique monoclonal antibody directed against a distinct antigenic determinant on the myoglobin molecule. Mouse monoclonal anti-myoglobin antibody is used for solid phase immobilization (on the microtiter wells). A goat anti-myoglobin antibody is in the antibody-enzyme (horseradish peroxidase) conjugate solution. The test sample is allowed to react simultaneously with the two antibodies, resulting in the myoglobin molecules being sandwiched between the solid phase and enzyme-linked antibodies. After a 45 minute incubation at room temperature, the wells are washed with water to remove unbound labeled antibodies. A TMB (Tetramethyl-benzidine) Reagent is added and incubated for 20 minutes, resulting in the development of a blue color. The color development is stopped with the addition of Stop Solution changing the color to yellow. The concentration of myoglobin is directly proportional to the color intensity of the test sample. Absorbance is measured spectrophotometrically at